These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 989476)

  • 21. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.
    Henney HR; Shah J
    Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative study of the activity of beta-adrenoceptor antagonists in man.
    Taylor SH; Thadani U; Davidson C; singleton W; Myint S
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):305-6. PubMed ID: 240783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect on plasma prolactin, growth hormone and luteinising hormone concentrations of single oral doses or propranolol and tolamolol in normal man.
    Saxton CA; Faulkner JK; Groom GV
    Eur J Clin Pharmacol; 1981; 21(2):103-8. PubMed ID: 6896183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute effects of tolamolol on renal function in hypertensive patients.
    Bianchi C; Bonadio M; Donadio C; Tramonti G; Figus S; Papalexiou P
    Experientia; 1976 Dec; 32(12):1565-6. PubMed ID: 1037307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioavailability of mifepristone in capsule versus tablet form in healthy nonpregnant women.
    Liao A; Pang X; Li H; Xiong Z; Wu X
    Contraception; 2008 Jun; 77(6):431-4. PubMed ID: 18477493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular beta-adrenergic blocking effects of bornaprolol in humans: relation to dose and plasma concentration.
    Cheymol G; Jaillon P; Lecoq B; Lecoq V; Cheymol A; Krumenacker M
    J Cardiovasc Pharmacol; 1987 Jun; 9(6):694-8. PubMed ID: 2442536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diclofenac potassium 25 mg liquid capsules: earlier and higher exposure to diclofenac. A fasted, single-dose, comparative bioavailability study vs. diclofenac potassium 2 x 12.5 mg tablets.
    Armogida M; Gold M
    Int J Clin Pharmacol Ther; 2012 Jun; 50(6):445-51. PubMed ID: 22677306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers.
    Ahmad M; Pervaiz F
    Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effects of tolamolol and propranolol on cardiac and peripheral circulatory function in patients with coronary artery disease.
    Miller RR; Vismara LA; Mason DT
    Clin Pharmacol Ther; 1975 Jun; 17(6):713-21. PubMed ID: 1095282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of metabolites in the relationship between pharmacokinetics and the effect of beta blockers. Studies on tolamolol and bufuralol].
    Tschopp JM; Gorgia A; Balant L; Revillard C; Francis RJ; Fabre FJ
    Schweiz Med Wochenschr; 1978 May; 108(20):756-64. PubMed ID: 26114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical and pharmacokinetic comparison of 2 oral preparations of nifedipine: 10 mg capsules and 20 mg delayed-release tablets].
    Vidal-Gárate J; Castañeda Hernández G; Hoyo Vadillo C; Herrera Abarca JE; Salazar LA; Moreno Ramos A; Fortino Chávez J; Tena I; Hong E
    Arch Inst Cardiol Mex; 1989; 59(1):73-80. PubMed ID: 2486739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical pharmacology of a new beta-adrenoceptor blocking drug, befunolol. Cross-over comparison with propranolol on repeated administration.
    Ebihara A; Tawara K; Oka T; Ofuji T; Kawahara K
    Eur J Clin Pharmacol; 1982; 23(3):189-95. PubMed ID: 6129139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biocomparison of Three Formulations of the S1P1 Receptor Modulator Ponesimod in Healthy Subjects.
    Juif PE; Hoch M; D'Ambrosio D; Dingemanse J
    Drugs R D; 2015 Jun; 15(2):203-10. PubMed ID: 25939333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Penbutolol and furosemide in a fixed-dose combination-bio-equivalence of two formulations.
    Meyer BH; Müller FO; Hundt HK; Grigoleit HG; Hajdu P; Heptner W
    S Afr Med J; 1981 Jun; 59(25):891-3. PubMed ID: 7015536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular effects of tolamolol (UK-6558), a new beta-adrenoreceptor blocking drug, in pinealectomized hypertensive rats.
    Karppanen H; Lahovaara S; Mattila MJ
    Ann Med Exp Biol Fenn; 1973 Mar; 51(3):104-11. PubMed ID: 4149365
    [No Abstract]   [Full Text] [Related]  

  • 36. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined pharmacokinetic and pharmacodynammc studies in man of the adrenergic beta1-receptor antagonist metoprolol.
    Johnsson G; Regårdh CG; Sölvell L
    Acta Pharmacol Toxicol (Copenh); 1975; 36(Suppl 5):31-44. PubMed ID: 1094802
    [No Abstract]   [Full Text] [Related]  

  • 38. Lack of bioequivalence between different formulations of isosorbide dinitrate and hydralazine and the fixed-dose combination of isosorbide dinitrate/hydralazine: the V-HeFT paradox.
    Tam SW; Sabolinski ML; Worcel M; Packer M; Cohn JN
    Clin Pharmacokinet; 2007; 46(10):885-95. PubMed ID: 17854237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clearance concept applied to pharmacokinetics: 2. Experience with tolamolol (beta-blocking agent) in renal insufficiency (author's transl)].
    Balant L; Gorgia A; Marmy A; Tschopp JM
    Nephrologie; 1980; 1(4):177-82. PubMed ID: 6895408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.